Home  |  About JAPTR |  Editorial board  |  Search |  Ahead of print  |  Current issue  |  Archives |  Submit article  |  Instructions  |  Subscribe  |  Advertise  |  Contacts  |Login 
Users Online: 244   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
     
This article has been cited by
1
Tabassum Zafar
.2020;()147
[DOI]
2Assessment of knowledge, attitude and practice regarding intellectual property rights among dental task force attending private dental colleges in Navi Mumbai: a cross-sectional study
Vaibhav Kumar,Venetia Aranha,Nikhil Bhanushali,Romi Jain,Swarali Atre,Shishir Singh
Journal of Medicine and Life.2021;14(1)93
[DOI]
3Assessment of knowledge, attitude and practice regarding intellectual property rights among dental task force attending private dental colleges in Navi Mumbai: a cross-sectional study
Basant Amarji,Sara Nidal Abed,Ujjawal Bairagi,Pran Kishore Deb,Omar Al-Attraqchi,Anup Avijit Choudhury,Rakesh K. Tekade
Journal of Medicine and Life.2018;14(1)637
[DOI]
4Assessment of knowledge, attitude and practice regarding intellectual property rights among dental task force attending private dental colleges in Navi Mumbai: a cross-sectional study
Priya Battu,Bhavya Mody,Sumit Rana,Kaushal Sharma
Journal of Medicine and Life.2021;14(1)113
[DOI]
5Assessment of knowledge, attitude and practice regarding intellectual property rights among dental task force attending private dental colleges in Navi Mumbai: a cross-sectional study
Vijay Laxmi,Mary Shobha Rani Inala
Journal of Medicine and Life.2021;14(1)95
[DOI]
6Fostering innovative product development for neglected tropical diseases through partnerships
Amy Starr,Katy M Graef,Jennifer Dent
Pharmaceutical Patent Analyst.2016;5(6)391
[DOI]
7Trans-Pacific Partnership Agreement and Its Impact on Accessibility and Affordability of Medicines: A Meta-synthesis
Yan Yee Yap,Che Pui Wong,Kah Seng Lee,Long Chiau Ming,Tahir Mehmood Khan
Therapeutic Innovation & Regulatory Science.2017;51(4)446
[DOI]
8Trans-Pacific Partnership Agreement and Its Impact on Accessibility and Affordability of Medicines: A Meta-synthesis
Mukesh Yadav,Maninder Meenu,Nirmala Sehrawat,Anil Kumar Sharma
Therapeutic Innovation & Regulatory Science.2019;51(4)79
[DOI]
9Trans-Pacific Partnership Agreement and Its Impact on Accessibility and Affordability of Medicines: A Meta-synthesis
Gerard Marshall Raj,Neel Jayesh Shah
Therapeutic Innovation & Regulatory Science.2019;51(4)353
[DOI]
10The role of intellectual property rights and package safety features in the prevention of counterfeit medicines
Katerina Ancevska-Netkovska,Katerina Brezovska,Nikola Geškovski,Jasmina Tonik-Ribarska,Biljana Petrovska-Jakimovska,Blagoj Achevski,Katerina Goracinova
Arhiv za farmaciju.2020;70(6)332
[DOI]
11The role of intellectual property rights and package safety features in the prevention of counterfeit medicines
Virendra Kumar Mishra,Hariom Verma,Gurudatta Singh
Arhiv za farmaciju.2019;70(6)159
[DOI]
12Polypharmacology Shakes Hands with Complex Aetiopathology
James S. Brodie,Vincenzo Di Marzo,Geoffrey W. Guy
Trends in Pharmacological Sciences.2015;36(12)802
[DOI]
13An overview of patents on therapeutic monoclonal antibodies in Europe: are they a hurdle to biosimilar market entry?
Evelien Moorkens,Arnold G. Vulto,Isabelle Huys
mAbs.2020;12(1)1743517
[DOI]
14Partnership Efforts – Their Potential to Reduce the Challenges that Confront Regulators and Pharmaceutical Industry
Sandeep Kumar Dhiman,Vikram Gummadi,Harish Dureja
Applied Clinical Research, Clinical Trials and Regulatory Affairs.2019;6(1)7
[DOI]
15Data Object Exchange (DOEx) as a Method to Facilitate Intraorganizational Collaboration by Managed Data Sharing: Viewpoint
Ronald G Hauser,Ankur Bhargava,Ronald Talmage,Mihaela Aslan,John Concato
JMIR Medical Informatics.2020;8(10)e19267
[DOI]
16Why do few drug delivery systems to combat neglected tropical diseases reach the market? An analysis from the technology’s stages
Jabson Herber Profiro de Oliveira,Igor Eduardo Silva Arruda,José Izak Ribeiro de Araújo,Luise Lopes Chaves,Mônica Felts de La Rocca Soares,José Lamartine Soares-Sobrinho
Expert Opinion on Therapeutic Patents.2021;8(10)1
[DOI]
17Why do few drug delivery systems to combat neglected tropical diseases reach the market? An analysis from the technology’s stages
Brian M. Cullum,Douglas Kiehl,Eric S. McLamore,J. P. Jasper,P. Farina,A. Pearson,P. S. Mezes,A. D. Sabatelli
Expert Opinion on Therapeutic Patents.2016;9863(10)98630M
[DOI]
18Why do few drug delivery systems to combat neglected tropical diseases reach the market? An analysis from the technology’s stages
Akansha Jain,Harikesh Bahadur Singh,Sampa Das
Expert Opinion on Therapeutic Patents.2019;9863(10)95
[DOI]
19Why do few drug delivery systems to combat neglected tropical diseases reach the market? An analysis from the technology’s stages
Badar Alam Iqbal,Arti Yadav
Expert Opinion on Therapeutic Patents.2020;9863(10)555
[DOI]
20Waiver of Intellectual Property Rights on COVID-19 vaccine roll out
Katherine Pia M Cabatbat
Journal of Public Health.2021;9863(10)555
[DOI]
  Feedback 
  Subscribe 




Most popular articles
Join us as a reviewer
Email alerts
Recommend this journal